Medizen Humancare Inc Co., Ltd Logo

Medizen Humancare Inc Co., Ltd

Offers DTC genetic testing and genomic analysis for personalized disease risk prediction.

236340 | KO

Overview

Corporate Details

ISIN(s):
KR7236340006
LEI:
Country:
South Korea
Address:
서울특별시 송파구 정의로7길 6 PNS홈즈타워 6층, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Medizen Humancare Inc Co., Ltd. is a biotechnology research company specializing in genomics-based personalized healthcare. Established in 2012, the company's core business is genomic analysis to predict individual disease risks. It provides direct-to-consumer (DTC) genetic testing and disease risk analysis services using genetic chips and analysis kits. By leveraging genomic big data, Medizen Humancare aims to advance precision medicine and deliver customized healthcare solutions based on an individual's genetic information.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-13 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-04-28 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 16.2 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.1 MB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 10.4 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 143.7 KB
2025-02-24 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.8 KB
2024-12-31 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 31.5 KB
2024-12-23 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 71.6 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-04 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.7 KB
2024-10-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2024-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 79.2 KB
2024-06-26 00:00
Related Party Transaction
타법인주식및출자증권취득결정
Korean 13.7 KB
2024-06-26 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 35.4 KB

Automate Your Workflow. Get a real-time feed of all Medizen Humancare Inc Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medizen Humancare Inc Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medizen Humancare Inc Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America
CCCC
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America
CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL
Camp4 Therapeutics Corp Logo
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America
CAMP
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden
CAMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.